The global Orthokeratology Lens Market size is expected to reach USD 1.08 billion by 2030, registering a CAGR of 6.5% during the forecast years, as per a new study by Grand View Research. Increasing efforts by key manufacturers in the market to launch new products and get regulatory approvals is the key factor driving the market growth. In addition, the ever-growing burden of patients with refractive errors is also majorly contributing to the growth of the market. For instance, according to a recent study published by The International Myopia Institute in 2022, an estimated 30% of the world’s population is myopic and by 2050, almost 50% of the population will be myopic. The outbreak of the COVID-19 pandemic had a negative impact on the market.
The
drop in sales of orthokeratology was due to reduced patient visits to the
hospitals and clinics to comply with the restrictions and guidelines laid down
by the governments to curb the spread of the virus. Moreover, the country-wise
lockdowns resulted in the disruption of demand and supply chain, which
negatively impacted the market growth. However, with the outbreak of the
pandemic, a major shift has been observed where a large number of people are
now more prone to develop refractive errors. The shift toward online school and
a large number of companies opting for work-from-home is expected to increase
the overall screen time of individuals, thereby contributing to the rise in
refractive errors. Thus, it can be anticipated that over the forecast years,
the market will undergo significant growth.
Related Press
Release@ Orthokeratology Lens Market Report
Orthokeratology Lens Market Report Highlights
- Based on
product type, the overnight ortho-K lenses dominated the market in terms
of revenue in 2021 due to easy product availability and higher adoption
rate
- Based on
indications, the myopia segment held the highest market share in 2021
owing to the higher prevalence of this refractive error and the easy
availability of ortho-K lenses for this indication
- The
ophthalmology clinics' distribution channel segment accounted for the
highest revenue share in 2021 due to the preference of patients to visit
the ophthalmologists in the clinics and purchase the recommended lenses
directly
- The COVID-19
pandemic had a slightly negative impact due to the reduction in patient
visits to hospitals and clinics
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment